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Alternative splicing usually leads to an increase in the number of gene products that can be
derived from a single transcript. Here, a different and novel use of alternative splicing – as a means
to control the amount of a potentially toxic gene product in the plant pararetrovirus Cauliﬂower
mosaic virus (CaMV) – is reported. About 70% of the CaMV 35S RNA, which serves as a
substrate for both reverse transcription and polycistronic mRNA, is spliced into four additional
RNA species. Splicing occurs between four donor sites – one in the 59 untranslated region and
three within open reading frame (ORF) I – and one unique acceptor site at position 1508 in ORF II.
A previous study revealed that the acceptor site is vital for CaMV infectivity and expression of
ORFs III and IV from one of the spliced RNA species suggested that splicing may facilitate
expression of downstream CaMV ORFs. However, it is shown here that deleting the splice
acceptor site and replacing ORF II with a cargo ORF that lacks splice acceptor sites does not
interfere with virus proliferation. Furthermore, it is demonstrated that whenever P2 cannot
accumulate in infected tissues, the splice acceptor site at position 1508 is no longer vital and
has little effect on virus replication. This suggests that the vital role of splicing in CaMV is regulation
of P2 expression and that P2 exhibits biological properties that, whilst indispensable for
virus–vector interactions, can block in planta virus infection if this regulation is abolished.
INTRODUCTION
Alternative RNA splicing is well-documented in animal
DNA viruses and retroviruses as a means of increasing
the number of mRNA species that are produced from
a primary transcript (Butsch & Boris-Lawrie, 2002;
Pongoski et al., 2002; Akusjarvi & Stevenin, 2003). Also,
in hepadnaviruses, including Hepatitis B virus (HBV;
Huang et al., 2000) and Duck hepatitis B virus (DHBV;
Loeb et al., 2002), several virus proteins have been demon-
strated to originate from spliced mRNA. In contrast, RNA
splicing events are much less well-documented for plant
viruses, regarding both their functional importance and
their role in regulating genome expression. In several
species of the family Geminiviridae, splicing of two major
RNA transcripts (C and V transcripts) has been reported
and characterized (Wright et al., 1997). Notably, processing
of the C transcript results in a fusion between two distinct
open reading frames (ORFs), allowing early expression of
the Rep protein that is required for virus replication. In the
family Caulimoviridae, splicing of the polycistronic 35S
RNA has been described in the genera ‘Rice tungro
bacilliform-like viruses’ and Caulimovirus, where it is
believed to enhance expression of downstream ORFs from
newly formed mRNAs (Kiss-La ´szlo ´ & Hohn, 1996; Hull,
2001). In Rice tungro bacilliform virus (RTBV), ORF (IV) of
the full-length RNA is expressed after removal of a 6?3 kbp
intron (Fu ¨tterer et al., 1994). However, the biological rele-
vance of the two cases of splicing that have been reported
in the genus Caulimovirus remains unclear; its role has
never been tested for Figwort mosaic virus (Scholthof et al.,
1991) and, as detailed below, is still undeﬁned for Cauli-
ﬂower mosaic virus (CaMV; Kiss-La ´szlo ´ et al., 1995).
CaMV is a pararetrovirus, the double-stranded DNA
genome of which is replicated by reverse transcription of
a pre-genomic 35S RNA. This 35S RNA is also used as a
polycistronic mRNA for all virus genes [reviewed by
Ryabova et al. (2002)]. In earlier work, several additional
RNA species that were detected in CaMV-infected plants
were suspected to originate from splicing of the 35S RNA
(Hirochika et al., 1985; Vaden & Melcher, 1990). That
splicing of the 35S RNA is an absolute requirement for
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(1995). These authors characterized four additional RNA
species (C1–C4) that are produced by splicing between four
donor sites and one unique acceptor site in the 35S RNA.
One of the donor sites is located in the long 59 untranslated
region (UTR) of the 35S RNA and the three others are
located within ORF I; the unique acceptor site is located in
the ﬁrst half of ORF II at nt 1508 [numbering according to
Franck et al. (1980)]. Mutations of the consensus sequence
of the splice acceptor site, designated ma1 and ma3
(changing AGG to CCG and AGA, respectively), totally
abolished splicing and were lethal for CaMV. Rare second-
site revertants eventually appeared upon deletion of the
central region of ORF II, which allowed the use of a cryptic
splice acceptor site that is located further downstream in
the ORF II sequence. Several hypotheses were proposed to
attribute a biological function to these splicing events, the
most commonly accepted of which postulates that splicing
might facilitate expression of the downstream genes (Kiss-
La ´szlo ´ & Hohn, 1996; Hull, 2001). Indeed, in RNA species
C4, in which the end of the 59 UTR is joined to the acceptor
site at position 1508, ORF III is moved to the position of
the ﬁrst translated ORF and efﬁcient translation of ORFs III
and IV from C4 RNA was veriﬁed in transient expression
experiments in protoplasts. Nevertheless, Kiss-La ´szlo ´ et al.
(1995) mentioned an alternative (but not mutually exclu-
sive) hypothesis, i.e. that the splicing events observed might
also serve to modulate expression of genes Iand/orII, which
can be translatedonly from the remaining 30%of unspliced
RNA. In this work, we reinvestigate the question of exactly
what feature of the splicing events characterized by Kiss-
La ´szlo ´ et al. (1995) is vital for CaMV.
ORF II is involved in aphid transmission [for a review, see
Blanc et al. (2001)] and is otherwise dispensable for host
plant infection, as demonstrated by the CaMV isolate CM4-
184, where a 421 bp deletion removes almost the entire
coding sequence of P2, the ORF II product (Howarth et al.,
1981). Surprisingly, and in apparent contradiction, several
amino acid changes in P2 are lethal for the virus (S. Blanc,
unpublished results), suggesting that, under some circum-
stances, P2 may be ‘toxic’ for virus replication and hence
may require very tight regulation (Pirone & Blanc, 1996;
Blanc et al., 2001). This led to the hypothesis that splicing
of 35S RNA is required to downregulate P2 accumulation,
and the prediction that the splicing event is vital only
wherefunctionalP2accumulates.Totestthishypothesis,we
produced a number of different CaMV mutants that were
debilitated in their capacity to accumulate P2 in infected
plants. As predicted, impairing 35S RNA splicing in these
mutant viruses was no longer lethal. Moreover, despite
disruption of the splice acceptor site at position 1508,
symptom appearance and virus accumulation in most of
these mutants was not modiﬁed, demonstrating that, in
the absence of P2, splicing per se has no important bio-
logical function in CaMV. Hence, we conclude that the vital
role of the splicing events analysed is downregulation of
P2 expression.
METHODS
Plasmids and mutant virus derivatives. All mutations (Fig. 1)
were engineered in the plasmid pCa37 (Franck et al., 1980) that con-
tained the full-length genome of CaMV Cabb-S strain, cloned at the
unique SalI restriction site in pBR322.
Two partially overlapping primers, Del-S-Forward and Del-S-Reverse,
were designed, with the overlap corresponding to the region between
nt 1375–1389 and 1811–1825 of Cabb-S. Del-S-Forward contained 16
additional nucleotides downstream of position 1825, corresponding
to the end of ORF II and the beginning of ORF III, whereas Del-S-
Reverse contained 14 additional nucleotides upstream of position
1375, in the 59 region of ORF II. Del-S-Forward and Del-S-Reverse
were used, together with primers RKpn (22 complementary nucleo-
tides overlapping the unique KpnI site at position 2039) and FBsiW
(22 forward nucleotides overlapping the unique BsiWI site at posi-
tion 208), respectively, to PCR-amplify two DNA fragments, both of
which contained a deletion within ORF II (spanning nt 1389–1811).
After this ﬁrst round of PCR ampliﬁcation, the two DNA fragments
obtained were heat-denatured in 0?16 TE buffer (1 mM Tris/HCl,
pH 8; 0?1 mM EDTA) and mixed in a 1:1 ratio before slow cooling.
An aliquot (10 ng) of this annealed DNA mixture was used as template
for a second round of PCR ampliﬁcation with primers RKpn and
FBsiW. The resulting chimeric PCR fragment was digested by KpnI
and BsiWI and was used to replace the corresponding fragment in
pCa37 to generate the clone CaMV Del-S.
The mutant CaMV DII-S was obtained similarly, with the partially
overlapping primers DIIS-Forward (59-AATAAACTAGTATGGCTA-
ATCTTAATC-39) and DIIS-Reverse (59-GCCATACTAGTTTATTCT-
CCACAGATTTC-39) instead of Del-S-Forward and Del-S-Reverse.
This construct resulted in a mutant that harboured a total deletion of
ORF II, with a unique SpeI restriction site separating ORFs I and III.
For mutants CaMV Top-S and Tart-S, similar chimeric PCR frag-
ments were again ampliﬁed from the template pCa37. For the ﬁrst
round of PCR, completely overlapping primers were used for both
constructs. These primers spanned nt 1343–1387 and 1340–1375 for
CaMV Top-S and Tart-S, respectively. For CaMV Top-S, the comple-
mentary overlapping primers contained a mutation that altered codon
6 of ORF II from CAA to TAA, thus introducing an early termination
codon. For CaMV Tart-S, the complementary overlapping primers
contained a mutation that altered the ATG of ORF II to AAG, thus
abolishing initiation of translation. The ﬁrst and second rounds of
PCR ampliﬁcation were performed as above with primers RKpn and
FBsiW and the ampliﬁed mutated fragments were introduced into
pCa37 at the BsiWI and KpnI restriction sites. To introduce the splic-
ing acceptor mutations ma1 or ma3 into Tart-S, the same procedure
was carried out on the plasmid templates pCa37ma1 and pCa37ma3
(Kiss-La ´szlo ´ et al., 1995).
CaMV-DIISthio was produced by introducing the Escherichia coli
thioredoxin gene, PCR-ampliﬁed from the plasmid pTrxFus (Invitro-
gen) and ﬂanked with SpeI restriction sites, into the corresponding
cloning site in CaMV-DIIS.
CaMV mut-S was constructed by amplifying the CaMV Cabb-S region
between the unique XhoI and KpnI sites with primers F-mut-S and
Rkpn. The 73 nt F-mut-S primer overlapped the XhoI site and the
downstream codon that corresponds to aa 116 of P2, which was
modiﬁed to encode an aspartic acid, instead of the original isoleucine.
The PCR fragment obtained was introduced into the XhoI and KpnI
restriction sites of pCa37. To combine mutations ma3 and mut-S,
we simply replaced the XhoI/KpnI fragment of plasmid pCa37ma3
(Kiss-La ´szlo ´ et al., 1995) with that of mut-S. All modiﬁed plasmids
created were veriﬁed by sequencing.
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Infectivity testing was performed by mechanical inoculation of
plasmid DNA into turnip hosts (Brassica rapa cv. Just Right) as
described by Melcher et al. (1986) and symptom appearance was
assessed visually daily for over 3 months. When symptoms were
fully developed in a host plant, the virus was transferred mechani-
cally to a new series of host plants by sap inoculation, with serial
passages being repeated three times. After each passage, viral DNA
was puriﬁed from systemically infected hosts as described by
Gardner & Shepherd (1980). The region that contained the mutation
of interest was PCR-ampliﬁed and sequenced. Whenever the intro-
duced mutation was maintained and no second-site revertant was
detected for at least one passage, the corresponding mutant was
declared to be infectious.
Protein analysis. To test for accumulation of virus and P2 (ORF
II product) in infected plant cells, we collected leaves with fully
developed symptoms and extracted the protein contents. Leaf
material (200 mg) was ground in 0?5 ml extraction buffer (200 mM
Tris/HCl, pH 7?6; 100 mM EGTA; 50 mM MgCl2;0 ?1% SDS) and
centrifuged at 10000 g for 10 min. The supernatant was then
submitted to 12% SDS-PAGE according to Laemmli (1970) and
separated proteins were transferred onto nitrocellulose membranes.
Detection of P2 and coat protein was performed with speciﬁc anti-
sera that were described by Blanc et al. (1993) and Karsies et al.
(2002), respectively.
RESULTS AND DISCUSSION
The mutants used in this study (Fig. 1) were obtained by
mutagenesis of the original pCa37 plasmid (Franck et al.,
1980) that contained the full-length genome of CaMV
isolate Cabb-S. All tests for infectivity and symptom
appearance are summarized in Table 1.
CaMV mutants that harbour a total deletion of
ORF II are viable
In isolate CM4-184 (Howarth et al., 1981), the sequence
deleted in ORF II includes the splice acceptor site at position
Fig. 1. CaMV genome mutants impaired in the expression of ORF II. First line represents CaMV Cabb-S (wild-type genome)
35S RNA from the 59 extremity to the end of ORF III. Small ORFs in the 59 UTR are shown as grey boxes. The splice donor
and acceptor sites described by Kiss-La ´szlo ´ et al. (1995) are indicated by black dots and squares, respectively, and their
position in the nucleotide sequence is indicated above [numbering according to Franck et al. (1980)]. All mutants used in this
study are represented below and their respective names are indicated on the left. The ORF II region remaining in CaMV Del-S
is detailed and is similar to that of the naturally occurring mutant CM4-184. Note: ‘g’ (indicated above the sequence)
corresponds to a nucleotide difference that creates a cryptic splice acceptor site in isolate CM4-184 (Kiss-La ´szlo ´ et al.,
1995) that is not present in Del-S. Insertions of SpeI cloning sites in CaMV DII-S and of a bacterial thioredoxin gene in CaMV
DII-Sthio are described in Methods. Mutations ma1 and/or ma3, described previously (Kiss-La ´szlo ´ et al., 1995), are shown by
black stars and the isoleucine (I) to aspartic acid (D) substitution at aa 116 of P2 is indicated in CaMV mut-S and its
derivative mutant mut-S-ma3. Dark boxes represent ORF II when translation is abolished; pale boxes represent functional
ORFs that can be translated into proteins.
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use of a cryptic acceptor site, located downstream of the
deleted region in the remaining ORF II sequence (Kiss-
La ´szlo ´ et al., 1995). We deleted exactly the same fragment
in the background of the wild-type isolate Cabb-S, to
generate the mutant Del-S. Due to nucleotide sequence
differences between Cabb-S and CM4-184, the deletion in
Del-S does not engender a putative cryptic splice acceptor
site such as that in CM4-184 (Fig. 1). Nevertheless, the
Del-S mutant was infectious (Table 1). To exclude the
possibility that an unpredicted sequence was used as a
new cryptic splice acceptor site in the remaining ORF II
sequence, we engineered the mutant DII-S so that the entire
ORF II sequence was replaced by a unique SpeI restriction
site. The CaMV DII-S mutant was also infectious, demon-
strating that, in the total absence of ORF II and, con-
sequently, of ORF II-based splice acceptor sites, CaMV can
still systemically infect its host.
Complete deletion of ORF II resulted in a 35S RNA with
ORF III being preceded solely by two ORFs (VII and I),
a situation comparable to that described in spliced RNA
species C1, C2 and C3 (Kiss-La ´szlo ´ et al., 1995), where ORF
III is preceded by ORF VII and an ORF I–II fusion product.
Thus, infectivity of DII-S might be enabled simply by the
reduction in the number of ORFs that precede ORF III. To
rule out this possibility, we increased the number of ORFs
again by including a bacterial thioredoxin gene (330 bp) at
the original position of ORF II. This modiﬁed 35S RNA is
very unlikely to be spliced in a manner comparable to that
of wild-type Cabb-S RNA, due to the absence of ORF II
and, thus, of the splice acceptor site at position 1508.
Nevertheless, CaMV DII-Sthio proved to be infectious. This
result indicates that the presence of three fully constituted
ORFs between the 59 UTR and ORF III in a 35S RNA that is
impaired in its splicing capacity is not in itself detrimental
to CaMV replication. It further suggests that it is speciﬁcally
the ORF II sequence itself that is lethal in splicing-impaired
35S RNA. Expression of a foreign gene from viable CaMV
mutants (DHFR or a interferon at the position of gene II)
has been described (Brisson et al., 1984; De Zoeten et al.,
1989) but, in those cases, and in contrast to DII-Sthio, the
ORF II sequences had not been totally removed.
All three mutants – CaMV Del-S, DII-S and DII-Sthio –
were delayed in symptom appearance (Table 1). We veriﬁed
that the modiﬁed sequences were stable and that no addi-
tional gene rearrangements or second-site reversions were
induced. Other than the absence of splicing, a reason for
the delay might be that ORF II includes one of the two
Table 1. Infectivity and timing of symptom appearance of various CaMV Cabb-S derivative mutants
Mutant* InfectionD P2 accumulationd Splice acceptor site§ Symptom delay||
CaMV Cabb-S + + + No delay
CaMV Cabb-S-ma1 2 NA 2 NA
CaMV Cabb-S-ma3 2 NA 2 NA
CaMV Del-S + 22 2–4 weeks
CaMV DII-S + 22 2–4 weeks
CaMV DII-Sthio + 22 2–4 weeks
CaMV Top-S (2) NA + 6–8 weeks
CaMV Tart-S + 2 + 2–4 weeks
CaMV Tart-S-ma1 + 22 2–4 weeks
CaMV Tart-S-ma3 + 22 2–4 weeks
CaMV mut-S + 2 + No delay
CaMV mut-S-ma3 + 22 1–3 days
*Mutant name and construction are described in Methods, except for Cabb-S-ma1 and ma3, which were
described by Kiss-La ´szlo ´ et al. (1995).
DExperiments were repeated four times, with 10 plants tested for each repetition. Mutants were considered to be
infectious after determining that test plants became infected with no second-site reversion or genome
rearrangements of the mutant CaMV. No. plants infected over the total no. plants tested varied between
repetitions but, in all cases of infectious mutants, the infection rate exceeded 30%.
dIn infectious mutants, the presence/absence of P2 was veriﬁed experimentally (Fig. 2). This column is not
applicable (NA) for non-infectious mutants.
§For the splice acceptor site at nt 1508, a plus sign corresponds to the wild-type sequence and a minus sign to
either the absence of the corresponding region or disruption by mutation ma1 or ma3 (Fig. 1).
||Cabb-S is the reference, compared to the other mutants. Experiments were repeated several times and delays in
symptom appearance varied, depending on the season and plant conditions, in a range indicated for each
mutant.
This mutant was infective only after second-site reversion (see text); hence, it is not considered to be infectious
here.
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synthesis (Bonneville & Hohn, 1993). The fact that
replication is delayed but not abolished is probably due to
the presence of an additional priming site for + strand
DNA synthesis located within ORF V, which is functionally
redundant with that in ORF II.
Preventing translation of P2 renders the splice
acceptor site in ORF II non-essential
To test the hypothesis that splicing in wild-type CaMV
is required to downregulate P2, we constructed CaMV
derivatives in which either the start codon of ORF II was
mutated from ATG to AAG (designated CaMV Tart-S) or
a premature stop codon was introduced at aa 6 of P2
(designated CaMV Top-S). The aim of this experiment was
to disable accumulation of P2 with minimal changes to
the CaMV genome sequence. Tart-S was fully infectious,
although symptom appearance was slightly delayed
(Table 1). In contrast, Top-S was not infectious without
acquisition of second-site reversions. In such cases, symp-
toms appeared after a considerable delay (6–8 weeks) and
the stop codon that was introduced had reverted to a new
amino acid codon (see one example in Fig. 2). Sequencing
and protein analysis controls carried out in parallel (Fig. 2)
demonstrated that no reversion had occurred in Tart-S at
this time. As wild-type CaMV Tart-S and Top-S theoreti-
cally produce the same spliced RNA species, no differences
in symptom development would be expected in the mutant,
compared to wild-type CaMV. The observed delay in
symptom appearance in the case of Tart-S is an indication
that the unspliced 35S RNA is used, at least partially, for
translation of genes downstream of ORF II, with the long
non-coding sequence (481 nt) that separates ORFs I and
III, and/or the short ORFs that are present in this region
in other reading frames, presumably interfering with the
polycistronic mode of CaMV translation (Ryabova et al.,
2002). In agreement with this latter explanation, we eventu-
ally observed a second-site revertant after several successive
passagesofTart-Sinhostplants,withanewinitiationcodon
(ATG) being created at aa 4 of the native ORF II (data not
shown). This restores ORF II, thus masking the small ORFs
that are present in other reading frames.
The fact that Top-S was not viable is similarly consistent
with the hypothesis that at least some translation of ORFs
that lie downstream of ORF II occurs from the unspliced
RNA.In this sense, thelethalityofTop-Smight be explained
by the presence of several short ORFs, including ORF II
truncated after six codons and short ORFs in other reading
frames, a situation that is unfavourable for reinitiation of
translation of polycistronic RNAs (Ryabova et al., 2002).
Again, as the Top-S mutation is located within the introns,
it should not have had any effect on CaMV replication if
translation of downstream genes was occurring solely from
spliced RNA species.
Mutations ma1 or ma3, which suppressed splicing totally
by disrupting the splice acceptor site at nucleotide position
1508 and were lethal for wild-type CaMV Cabb-S (Kiss-
La ´szlo ´ et al., 1995), were introduced in the Tart-S mutant
background to generate CaMV Tart-S-ma1 and Tart-S-
ma3. Interestingly, both proved to be infectious, with no
detectable delay in symptom appearance compared to Tart-
S (Table 1). These results conﬁrm that, when P2 cannot be
translated and thus does not accumulate in infected tissues
(Fig. 2), disruption of the splice acceptor site at position
1508 no longer interferes with the CaMV infection cycle
and has little or no effect on the timing of infection. We
checked the virus progeny carefully by sequencing the whole
ORF II region and observed neither direct reversion of
ma1 or ma3, nor second-site reversions of any sort.
CaMV mutants expressing unstable P2 are not
affected by their splicing capability
Amino acid changes in the C-terminal a-helix 1 of P2
resulted in the complete absence of P2 accumulation in
CaMV-infected plants by serendipity (He ´brard et al., 2001),
which was explained by induced conformational changes
leading to protein instability. Accordingly, we assumed that
the mutation I116D in P2 (CaMV mut-S) would also
prevent P2 accumulation, as position 116 falls into the
hydrophobic interface that is responsible for the formation
of coiled-coil structures that lead to P2 self-interaction
(He ´brard et al., 2001). This additional construct is of
particular interest. It was created in order to yield a mutant
as comparable as possible to wild-type CaMV, where all
Fig. 2. Accumulation of coat protein and P2 on infection of
turnip with CaMV mutants. Total protein extracts of CaMV-
infected turnips (60 days post-infection) were prepared as
described in Methods. Samples were submitted to 12% SDS-
PAGE and transferred to nitrocellulose membranes before spe-
ciﬁc immunostaining of coat protein (top), as a control of virus
accumulation, and P2 protein (below). Virus accumulation in all
mutants (lanes 2–7) is comparable to that in wild-type CaMV
Cabb-S (lane 1). P2 protein accumulates in the wild-type
CaMV Cabb-S (lane 1) and in revertants obtained from the
mutant Top-S (one example is shown in lane 7), but is never
detected in mutants Tart-S, Tart-S-ma1, Tart-S-ma3, mut-S or
mut-S-ma3 (lanes 2–6, respectively). Molecular mass marker
positions are indicated in kDa on the left. The very faint band
observed slightly above the position of P2 in lanes 2, 3, 6 and
7 is a sporadically appearing, non-speciﬁc staining.
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but where the ORF II gene product P2 would nevertheless
be absent. As mut-S has no modiﬁcation that is predicted
to affect genome translation or replication, in contrast to
all other mutants described above, we expected this mutant
to be infectious without any noticeable delay in symptom
appearance when compared with wild-type Cabb-S.
We ﬁrst veriﬁed that mut-S was viable and displayed no
delays in symptom appearance (Table 1), then veriﬁed the
absence of P2 in infected tissues (Fig. 2). Mutation ma3
was then introduced in mut-S to yield CaMV mut-S-ma3,
which was assessed for infectivity. Table 1 shows that it is
indeed infectious, with very short delays (if any) in symp-
tom appearance, further conﬁrming that the splice acceptor
site at position 1508 of CaMV Cabb-S is not essential in the
absence of P2 accumulation in infected plants. Moreover,
the very short delays that were recorded in disease develop-
ment on infection of plants with CaMV mut-S-ma3,
together with normal virus accumulation in infected tissues
(Fig. 2), suggest that splicing of the 35S RNA of CaMV
(Kiss-La ´szlo ´ et al., 1995) has no major biological function
other than regulating expression of P2. However, as very
short delays did sometimes occur, we could not totally
exclude a secondary, minor, dispensable effect that was
caused either by enhancement of translation of downstream
ORFs or modulation of P1 expression, or both.
Three of the four spliced RNA species C1–C4 contain
in-frame fusions between ORFs I and II, the putative
function of which was questioned by Kiss-La ´szlo ´ et al.
(1995). As demonstrated here, the presence or absence of
such P1–P2 fusions (mutants with an unmodiﬁed acceptor
site at position 1508, and any mutant ma1 or ma3 where the
acceptor site is disrupted, respectively) is not critical for
CaMV viability. We therefore believe that these putative
fusion proteins have no function, at least in the absence
of P2, and are rather unstable, underlined by the fact that
they were barely detectable in infected tissues (Kiss-La ´szlo ´
et al., 1995). We propose that the P1–P2 fusions in RNA
species C2, C3 and C4 are in-frame in order to prevent the
deleterious appearance of many small ORFs that would
result from out-of-frame fusions. This idea is supported
by the lack of infectivity of our mutant Top-S, demon-
strating that a series of small ORFs located between coding
ORFs is deleterious for the CaMV life cycle.
Spliced RNA species are extremely difﬁcult to detect in
CaMV-infected plants, due to the presence of many par-
tially digested virus RNA molecules that are released during
reverse transcription (Kiss-La ´szlo ´ et al., 1995). For this
reason, we did not analyse putative alternative spliced RNA
species in our various mutants, but designed the latter to
allow solid conclusions from simple testing of infectivity,
timing of symptom appearance and virus and P2 accumula-
tion. The logic underlying the design of the mutants used
is discussed above, together with the results in each case,
but we draw attention particularly to the comparison of
mutants mut-S and mut-S-ma3. The change in mut-S is
restricted to a single amino acid change in the last third
of the protein. Whilst it results in the total disappearance of
P2, it affects neither virus ﬁtness, as judged by timing of
infection (Table 1), nor virus accumulation (Fig. 2). The
ma3 disruption of the splice acceptor site at position 1508
has virtually no effect on mut-S (Table 1; Fig. 2), whilst it
kills wild-type Cabb-S. The only difference between the two
is the presence/absence of P2; thus, the most logical conclu-
sion is that P2 aborts CaMV infection in the absence of
splicing. Indeed, other hypotheses that invoke putative
alternative splicing events that could compensate for the
ma3 mutation in mut-S are very unlikely, as these alter-
native splicing events obviously do not occur in the wild-
type Cabb-S.
Pirone & Blanc (1996) ﬁrst suggested the hypothetical
requirement for tight regulation of P2 expression and
accumulation. They speculated that the properties of P2
that are required for aphid transmission might, in turn, be
‘toxic’ for the virus replication cycle or cell-to-cell move-
ment. Thus, precise mechanisms of regulation may exist to
harmonize the different steps of the CaMV life cycle: plant
invasion versus aphid transmission. Here, we provide the
ﬁrstindirectexperimental evidenceforsuchtoxicproperties
by showing that, whilst P2 can be removed totally without
abolishing host plant infection, its accumulation can be
lethal in the absence of splicing of the 35S RNA. At this
point, we can speculate that some properties of P2 may
potentially interfere with CaMV infection. The afﬁnity of P2
for the microtubule network of the host cell (Blanc et al.,
1996) or its association with the virion–P3 complex for
aphid transmission (Schmidt et al., 1994; Leh et al., 1999,
2001) appear to be good candidates. Both properties might
interfere with replication or cell-to-cell movement and
unregulated binding to the P3–virion complex could, for
instance, mask the nuclear localization signal motif of the
coat protein and prevent nuclear targeting of the virions.
It was shown that P3 is also required for cell-to-cell
movement (Kobayashi et al., 2002) and that P3 virions
interact with the movement protein (L. Stavolone, personal
communication). P2 could inhibit such an interaction and,
consequently, cell-to-cell movement. Surprisingly, it was
demonstrated recently that, in infected plant cells, P2 is
not massively bound either to virion–P3 complexes or to
the microtubule network. Instead, it is stored entirely
within speciﬁc, electron-lucent inclusion bodies (ELIBs) as
P2–P3 aggregates (Drucker et al., 2002). The mechanisms
that sequester P2 in these ELIBs remain to be discovered,
but P3 may play a pivotal role. In this sense, when P3 is
targeted to the ELIB together with P2, one could postulate
that the P3/P2 ratio is important and might be regulated
by the splicing events that are discussed here. Whilst P3 is
probably expressed from both spliced and unspliced viral
RNAs, P2 can be derived only from unspliced 35S species.
More generally, alternative RNA splicing is commonly
interpreted as producing new RNA species that allow
(or enhance) the expression of a protein with a speciﬁc
2724 Journal of General Virology 85
R. Froissart and othersbiological function (Huang et al., 2000; Kondrashov &
Koonin, 2003; Kriventseva et al., 2003; Lu & Cullen, 2003).
To the best of our knowledge, the work presented here is
the ﬁrst example of a splicing event of which the primary
purpose appears to be prevention of excess accumulation
of a speciﬁc gene product that would otherwise be produced
from the unspliced RNA.
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